Braemar Guides 2027 Revenue Above Consensus, Settles Proxy War
BHR is trading near its 52-week low of $1.445 (5.9% above the low).
Summary
Braemar issued 2027 revenue guidance of $407M-$412M, above the $401M consensus, with adjusted FFO of $0.25-$0.31 and RevPAR growth of 4.5%-6.5%. The company also announced a cooperation and settlement agreement with activist Al Shams Investments, ending the proxy contest and withdrawing board nominations. This follows the $372M Four Seasons Scottsdale sale agreement and the $40M settlement disclosed in today's 8-K filings. The guidance and settlement remove a major overhang and provide a clearer post-transformation outlook.
At the time of this announcement, BHR was trading at $1.53 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $102.3M. The 52-week trading range was $1.45 to $3.19. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.